>

Male balding (stage 3, lateral)

Q: Can I use the Male balding (stage 3, lateral) icon in a BioRender figure or scientific illustration?

Yes — the Male balding (stage 3, lateral) is fully integrated into BioRender's drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you're building from scratch or starting with a BioRender template.

Q: Can I export figures that include the Male balding (stage 3, lateral) icon for publication or presentations?

Yes — figures containing the Male balding (stage 3, lateral) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

Male balding (stage 3, lateral) - Editable icon of stage 3 balding shown on a male head in a lateral view

[{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630dd/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630dd/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630de/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630de/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630df/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630df/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630e0/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630e0/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630e1/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630e1/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630e2/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630e2/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630e3/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630e3/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630e4/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630e4/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630e5/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630e5/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630e6/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630e6/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630e7/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630e7/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630e8/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630e8/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630e9/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630e9/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630ea/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630ea/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630eb/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630eb/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630ec/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630ec/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630ed/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630ed/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630ee/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630ee/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630ef/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630ef/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630f0/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630f0/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630f1/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630f1/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630f2/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630f2/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630f3/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630f3/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630f4/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630f4/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630f5/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630f5/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630f6/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630f6/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630f7/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630f7/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630f8/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630f8/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630f9/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630f9/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630fa/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630fa/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630fb/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630fb/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630fc/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630fc/670fd5ac27eb8f96be063089.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/670fd5e927eb8f96be0630fd/670fd5ac27eb8f96be063089.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/670fd5e927eb8f96be0630fd/670fd5ac27eb8f96be063089.png"}]

Keywords

keyword text

male balding (stage 3),stage 3,balding,Norwood scale,Norwood,Norwood 5,hair,full hair,person,people,head,face,male,man,boy,guy,face,bald,hair loss,adult,mature,grown,full-grown,young adult,middle adult,old adult,generic,neutral,standard,default,undefined,unspecified,universal,all-race,all-ethnicity,basic figure,standard figure,silhouette,shape,outline,shadow,simple,simple figure,black figure,body outline,silhouetted,lateral,side view,side,lateral view,

BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More

More Icons like this one in

Related Categories

Back To Library Home

Join 1,500,000 other scientists on BioRender

Sign up for your free account and start creating scientific figures faster today

Sign Up Free

FAQs

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Male balding (stage 3, lateral) icon along with our library of more than 30,000 life science icons.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Male balding (stage 3, lateral) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Male balding (stage 3, lateral) icon customizable in BioRender?

Most icons in BioRender, including the Male balding (stage 3, lateral) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

How are scientists using the Male balding (stage 3, lateral) icon in their work?

BioRender users often use the Male balding (stage 3, lateral) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Human Anatomy.

Can I export figures that include the Male balding (stage 3, lateral) icon for publication or presentations?

Yes, figures containing the Male balding (stage 3, lateral) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

Is the Male balding (stage 3, lateral) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Male balding (stage 3, lateral) icon — especially those focused on Human Anatomy. You can search BioRender’s template library or add this icon manually to any canvas.

Make scientific figures in minutes

Male balding (stage 3, lateral)

Join 1,500,000 other scientists on BioRender

FAQs

Looking for science content?